Collaboration is the key to reducing the incidence and burden of liver disease. As the leading global association in the field of hepatology, EASL is keen to work with industry partners concerned with the health and well-being of patients across the globe.
While EASL is widely known for its annual flagship event, The International Liver Congress™ (ILC), many other scientific conferences and educational initiatives are organised to advance excellence in hepatology throughout the year. A number of such activities are funded through an Annual Unrestricted Grant supported by industry partners.
The EASL’s mission is supported by an unrestricted education grant from Abbvie, Bristol-Myers Squibb and Gilead.